Major update for anyone taking Atorvastatin after huge trial

All you need to know as a study found that atorvastatin reduced major cardiovascular event risk by 30% however, it did not significantly improve disability-free survival

MediaNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.mirror.co.uk)